Feasibility of a Novel Autoinflation Device to Treat Pediatric Otitis Media With Effusion At-Home

Maria-Jose Soto1, Nanki Hura2, Intan Oldakowska1

  • 1Centre for Medical Research at the University of Western Australia Crawley Western Australia Australia.

OTO Open
|May 15, 2025
PubMed

Insights

A novel autoinflation device shows promise for treating children with otitis media with effusion (OME). At-home use improved middle ear pressure and hearing loss in most patients within 4 weeks.

Area of Science:

  • Pediatric Otolaryngology
  • Biomedical Engineering
  • Audiology

Background:

  • Otitis media with effusion (OME) is highly prevalent in children, often leading to conductive hearing loss.
  • Current guidelines recommend tympanostomy tubes for persistent OME, but non-surgical options are limited.
  • Prolonged OME can risk long-term hearing impairment, necessitating effective interventions.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of a novel prototype autoinflation device for home use in children with OME or eustachian tube dysfunction.
  • To assess the impact of the device on middle ear pressure and hearing outcomes.
  • To determine patient compliance with at-home autoinflation therapy.

Main Methods:

  • A single-arm cohort study involving 21 children aged 1-12 years with OME.
  • Participants used the autoinflation device twice daily for 4 weeks.
  • Audiometry and tympanometry were performed at baseline, with follow-up tympanometry and 4-week audiometry; compliance was tracked via an app.

Main Results:

  • 86% of patients showed improved middle ear pressure after one session, maintained by 83% at 4 weeks.
  • 86% of patients with baseline hearing loss demonstrated improvement at 4 weeks.
  • Average pure tone average improved from 26.8 to 18.9 dB HL in affected ears.

Conclusions:

  • The autoinflation device demonstrated significant improvements in tympanometry and audiometry outcomes.
  • Regular middle ear ventilation using this device shows strong potential benefits for pediatric OME patients.
  • Home-based autoinflation offers a promising non-surgical approach for managing OME during watchful waiting periods.
Abstract